A study in healthy men to test whether BI 1015550 influences the amount of nintedanib and pirfenidone in the blood

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-505522-34-00

Acronym

1305-0034

Enrollment

Registered

2023-09-22

Start date

2023-11-08

Completion date

2023-12-14

Last updated

2023-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer trial

None listed

Sex/Gender

Male

Age

18 Years to 64 Years

Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026